*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C862 - Enteropathy-type (intestinal) T-cell lymphoma - as a primary diagnosis code | C862 - Enteropathy-type (intestinal) T-cell lymphoma - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 9.09 | |
| Readmission Rate (%) | 42.31 | |
| Unplanned Readmission Rate (%) | NA | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 29,081 |
| Total Hospitalizations with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | 18 |
| DRG Share of Total Hospitalizations | 0.09 |
| % of Total ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma in DRG | 32.73 |
| Avg LOS at DRG | 9.8 |
| Avg LOS with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | 10.06 |
| Readmission Rate at DRG | 37.3 |
| Readmission Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | NA |
| Unplanned Readmission Rate at DRG | 22.57 |
| Unplanned Readmission Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | NA |
| Total Medicare payments at DRG | $683,745,757 |
| Total Medicare payments with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $383,151 |
| Total Medicare payment per Day at DRG | $2,399 |
| Total Medicare payment per Day with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $2,117 |
| Total Medicare payment per Hospitalization at DRG | $23,512 |
| Total Medicare payment per Hospitalization with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $21,286 |
| Total Medicare Charges at DRG | $3,049,100,784 |
| Total Medicare Charges with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $1,974,495 |
| Avg Charges at DRG | $104,849 |
| Avg Charges with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $109,694 |
| Mortality Rate at DRG | 13.07 |
| Mortality Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | NA |
| SNF Discharge Rate at DRG | 16.93 |
| SNF Discharge Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | NA |
| Home Discharge Rate at DRG | 29.4 |
| Home Discharge Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 820: LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|
| Total Hospitalizations at DRG | 45,065 | ||
| Total Hospitalizations with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | 19 | ||
| DRG Share of Total Hospitalizations | 0.14 | ||
| % of Total ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma in DRG | 12.67 | ||
| Avg LOS at DRG | 4.03 | ||
| Avg LOS with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | 3.53 | ||
| Readmission Rate at DRG | 66.75 | ||
| Readmission Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | 78.95 | ||
| Unplanned Readmission Rate at DRG | 10.94 | ||
| Unplanned Readmission Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | NA | ||
| Total Medicare payments at DRG | $438,494,977 | ||
| Total Medicare payments with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $182,648 | ||
| Total Medicare payment per Day at DRG | $2,416 | ||
| Total Medicare payment per Day with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $2,726 | ||
| Total Medicare payment per Hospitalization at DRG | $9,730 | ||
| Total Medicare payment per Hospitalization with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $9,613 | ||
| Total Medicare Charges at DRG | $2,145,591,374 | ||
| Total Medicare Charges with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $786,514 | ||
| Avg Charges at DRG | $47,611 | ||
| Avg Charges with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | $41,395 | ||
| Mortality Rate at DRG | 0.08 | ||
| Mortality Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | NA | ||
| SNF Discharge Rate at DRG | 4.35 | ||
| SNF Discharge Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | NA | ||
| Home Discharge Rate at DRG | 81.76 | ||
| Home Discharge Rate with ICD C862 - Enteropathy-type (intestinal) T-cell lymphoma | 100.0 |